Clene Inc.
Qualité des données : 100%
CLNN
Nasdaq
Manufacturing
Chemicals
6,29 €
▼
0,11 €
(-1,72%)
Cap. Boursière: 74,09 M
Prix
6,29 €
Cap. Boursière
74,09 M
Fourchette du Jour
6,15 € — 6,44 €
Fourchette 52 Semaines
2,28 € — 13,50 €
Volume
55 679
Ouverture 6,38 €
Moyenne 50J / 200J
5,02 €
25,38% above
Moyenne 50J / 200J
5,98 €
5,17% above
Quick Summary
Points Clés
Revenue declined -27,48% annually over 5 years
Negative free cash flow of -18,59 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,04%
Croissance
Revenue Growth (5Y)
-27,48%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-41,52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-127,72%
Net Margin-13086,50%
Op. Margin-11541,50%
Sécurité
Debt / Equity
N/A
Current Ratio1,53
Interest Coverage-8,61
Valorisation
PE (TTM)
-2,83
En dessous de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,8 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,5 |
| Net Margin % | -13086,5 | -41,5 |
| Rev Growth 5Y % | -27,5 | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -41,52% | Revenue Growth (3Y) | -44,70% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -27,48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 200 000,0 | Net Income (TTM) | -26,17 M |
| ROE | N/A | ROA | -117,80% |
| Gross Margin | N/A | Operating Margin | -11541,50% |
| Net Margin | -13086,50% | Free Cash Flow (TTM) | -18,59 M |
| ROIC | -127,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,53 |
| Interest Coverage | -8,61 | Asset Turnover | 0,01 |
| Working Capital | 4,37 M | Tangible Book Value | -12,36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,83 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 370,43 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -25,09% | ||
| Market Cap | 74,09 M | Enterprise Value | 84,04 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0,02 |
| FCF / Share | -1,58 | OCF / Share | -1,57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 19,50% | FCF Conversion | 71,01% |
| SBC-Adj. FCF | -25,79 M | Growth Momentum | -14,04 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200 000,0 | 342 000,0 | 654 000,0 | 473 000,0 | 723 000,0 |
| Net Income | -26,17 M | -39,40 M | -49,50 M | -29,92 M | -9,74 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -23,08 M | -33,09 M | -40,54 M | -48,41 M | -49,98 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 14,01 M | 20,06 M | 26,66 M | 31,92 M | 28,42 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 2,68 M | 4,06 M | 4,56 M | -3,30 M | 870 000,0 |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | -428 000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18,13 M | 27,34 M | 52,34 M | 44,49 M | 63,06 M |
| Total Liabilities | 35,72 M | 36,19 M | 38,95 M | 41,26 M | 50,47 M |
| Shareholders' Equity | -17,59 M | -8,86 M | 13,39 M | 3,24 M | 12,60 M |
| Total Debt | 17,79 M | — | — | — | — |
| Cash & Equivalents | 5,19 M | 12,16 M | 28,82 M | 18,33 M | 50,35 M |
| Current Assets | 8,98 M | 16,16 M | 38,85 M | 29,20 M | 54,58 M |
| Current Liabilities | 10,78 M | 10,29 M | 25,33 M | 13,86 M | 6,03 M |
{"event":"ticker_viewed","properties":{"ticker":"CLNN","listing_kind":"stock","pathname":"/stocks/clnn","exchange":"Nasdaq","country":"US"}}